There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Radnet (RDNT – Research Report), Chemed (CHE – Research Report) and UnitedHealth (UNH – Research Report) with bullish sentiments.
Radnet (RDNT)
In a report released today, David S Macdonald from Truist Financial maintained a Buy rating on Radnet, with a price target of $38.34. The company’s shares closed last Tuesday at $38.34, close to its 52-week high of $39.55.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Radnet with a $42.17 average price target, which is a 9.0% upside from current levels. In a report issued on February 21, Sidoti also maintained a Buy rating on the stock with a $46.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Chemed (CHE)
Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Chemed today and set a price target of $625.00. The company’s shares closed last Tuesday at $596.60, close to its 52-week high of $610.35.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of
Currently, the analyst consensus on Chemed is a Moderate Buy with an average price target of $652.50, an 8.8% upside from current levels. In a report issued on February 14, Bank of America Securities also reiterated a Buy rating on the stock with a $680.00 price target.
UnitedHealth (UNH)
TD Cowen analyst Gary Taylor maintained a Buy rating on UnitedHealth today and set a price target of $607.00. The company’s shares closed last Tuesday at $513.42.
According to TipRanks.com, Taylor is a 1-star analyst with an average return of
Currently, the analyst consensus on UnitedHealth is a Strong Buy with an average price target of $599.57.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RDNT:
- RDNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- RadNet to Enter the Houston, Texas Market through Platform Acquisition of Houston Medical Imaging
- RadNet and JVS SoCal Create ImagingWorks®, an Innovative Partnership to Launch Career Training Programs for Medical Imaging
- RadNet, Inc. Announces Date of its Fourth Quarter 2023 Financial Results Conference Call
- RadNet’s radiology Joint Venture acquires seven imaging centers in Arizona
